Gapping down
In reaction to disappointing earnings/guidance: CPB -5.4%.
M&A news: AZN -9.3% (Co rejects Pfizer's (PFE) final proposal), AMX -5.2% (AT&T (T) to divest interest in AMX to facility regulatory approval process in Lat Am), T -2.4% (AT&T (T) to Acquire DIRECTV for $95 per share), SHLD -2% (Sears Canada announced sale of its minority interest in Trois-Rivieres joint arrangement).
Select EU financial related names showing weakness: NBG -3%, DB -2.3% (raises capital and reaffirms Strategy 2015+), BCS -1.9%, RBS -1.3%, ING -1.1%, UBS -1.1%
Other news: MELI -2.6% (to report Venezuela results at SICAD II exchange rate; expects to incur a one-time re-measurement charge of $47-57 mln in Q2), GME -1.7% (unfavorable Mad Money mention), SNE -1.5% (Bloomberg real M&A column discusses possibility of SNE breakup).
Analyst comments: GNW -2.9% (downgraded to Underweight from Equal-Weight at Morgan Stanley), CSIQ -1.4% (target lowered to $46 from $52 at Northland Capital), ATK -1% (downgraded to Neutral from Buy at Goldman), MO -1% (downgraded to Market Perform from Outperform at Wells Fargo), KMB -0.9% (downgraded to Hold from Buy at Argus).
In reaction to disappointing earnings/guidance: CPB -5.4%.
M&A news: AZN -9.3% (Co rejects Pfizer's (PFE) final proposal), AMX -5.2% (AT&T (T) to divest interest in AMX to facility regulatory approval process in Lat Am), T -2.4% (AT&T (T) to Acquire DIRECTV for $95 per share), SHLD -2% (Sears Canada announced sale of its minority interest in Trois-Rivieres joint arrangement).
Select EU financial related names showing weakness: NBG -3%, DB -2.3% (raises capital and reaffirms Strategy 2015+), BCS -1.9%, RBS -1.3%, ING -1.1%, UBS -1.1%
Other news: MELI -2.6% (to report Venezuela results at SICAD II exchange rate; expects to incur a one-time re-measurement charge of $47-57 mln in Q2), GME -1.7% (unfavorable Mad Money mention), SNE -1.5% (Bloomberg real M&A column discusses possibility of SNE breakup).
Analyst comments: GNW -2.9% (downgraded to Underweight from Equal-Weight at Morgan Stanley), CSIQ -1.4% (target lowered to $46 from $52 at Northland Capital), ATK -1% (downgraded to Neutral from Buy at Goldman), MO -1% (downgraded to Market Perform from Outperform at Wells Fargo), KMB -0.9% (downgraded to Hold from Buy at Argus).